Technetium-99m-labeled long chain fatty acid analogues metabolized by β-oxidation in the heart

Journal of Medicinal Chemistry

Volumn 50, Issue 3, 2007, Pages 543-549

  Uehara, Tomoya ^a   Uemura, Tomoe ^a   Hirabayashi, Seiji ^a   Adachi, Sayaka ^a   Odaka, Kenichi ^b   Akizawa, Hiromichi ^a   Magata, Yasuhiro ^c   Irie, Toshiaki ^b   Arano, Yasushi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPENTADIENYLTRICARBONYL TC 99M; LONG CHAIN FATTY ACID; RHENIUM 188; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG STRUCTURE; DRUG SYNTHESIS; ENERGY YIELD; FATTY ACID OXIDATION; HEART MUSCLE; NONHUMAN; RADIOACTIVITY; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; ENERGY METABOLISM; FATTY ACIDS; IODOBENZENES; MYOCARDIUM; ORGANOTECHNETIUM COMPOUNDS; OXIDATION-REDUCTION; RATS; TECHNETIUM; TISSUE DISTRIBUTION;

EID: 33846906434     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm061017g     Document Type: Article

References (41)

1. Koonen, D. P.; Glatz, J. F.; Bonen, A.; Luiken, J. J. Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochim. Biophys. Acta. 2005, 1736, 163-180.
2. van der Vusse, G. J.; Glatz, J. F.; Stam, H. C.; Reneman, R. S. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol. Rev. 1992, 72, 881-940.
3. Corbett, J. R. Fatty acids for myocardial imaging. Semin. Nucl. Med. 1999, 29, 237-258.
4. Nishimura, S.; Ohta, Y. BMIPP in angina pectoris. Int. J. Card. Imaging 1999, 15, 35-39.
5. Shikama, N.; Nakagawa, T.; Takiguchi, Y.; Aotsuka, N.; Kuwabara, Y1; Komiyama, N.; Terano, T.; Hirai, A. Assessment of myocardial perfusion and fatty acid metabolism in a patient with Churg-Strauss syndrome associated with eosinophilic heart disease. Circ. J. 2004, 68, 595-598.
6. Schelbert, H. R. PET contributions to understanding normal and abnormal cardiac perfusion and metabolism. Ann. Biomed. Eng. 2000, 28, 922-929.
7. 99mTc DIARS and DMPE complexes containing pentadecanoic acid. Int. J. Radiat. Appl. Instrum, Part B 1987, 14, 545-553.
8. 99mTc-carbonyltechnetium-labeled fatty acids. Appl. Radiat. Isot. 2004, 60, 845-850.
9. Jones, G. S. J.; Elmaleh, D. R.; Strauss, H. W.; Fischman, A., J. 7, 10-Bis(2-mercapto-2-methyl)propyl-7,10-diazapalmitic acid: A novel, N2S2 ligand for technetium-99m. Bioorg. Med. Chem. Lett. 1996, 6, 2399-2404.
10. Jung, C. M.; Kraus, W.; Leibnitz, P.; Pietzsch, H.-J.; Kropp, J.; Spies, H. Syntheses and first crystal structures of rhenium complexes derived from ω-functionalized fatty acids as model compounds of technetium tracers for myocardial metabolism imaging. Eur. J. Inorg. Chem. 2002, 5, 1219-1225.
11. Karesh, S. M.; Eckelman, W. C.; Reba, R. C. Biological distribution of chemical analogs of fatty acids and long chain hydrocarbons containing a strong chelating agent. J. Pharm. Sci. 1977, 66, 225-228.
12. Liang, F. H.; Virzi, F.; Hnatowich, D. J. The use of diaminodithiol for labeling small molecules with technetium-99m. Int. J. Radiat. Appl. Instrum., Part B 1987, 14, 63-67.
13. 99mTc-labeled fatty acid analogs for myocardial imaging. Int. J. Radiat. Appl. Instrum., Part B 1991, 18, 215-226.
14. Maresca, K. P.; Shoup, T. M.; Femia, F. J.; Burker, M. A.; Fischman, A.; Babich, J. W.; Zubieta, J. Synthesis, characterization, and biodistribution of a Technetium-99m '3+1 fatty acid derivative. The crystal and molecular structures of a series of oxorhenium model complexes. Inorg. Chim. Acta. 2002, 338, 149-156.
15. Yamamura, N.; Magata, Y.; Arano, Y.; Kawaguchi, T.; Ogawa, K.; Konishi, J.; Saji, H. Technetium-99m-labeled medium-chain fatty acid analogues metabolized by beta-oxidation: radiopharmaceutical for assessing liver function. Bioconjugale Chem. 1999, 10, 489-495.
16. Magata, Y.; Kawaguchi, T.; Ukon, M.; Yamamura, N.; Uehara, T.; Ogawa, K.; Arano, Y.; Temma, T.; Mukai, T.; Tadamura, E.; Saji, H. A Tc-99m-labeled long chain fatty acid derivative for myocardial imaging. Bioconjugate Chem. 2004, 15, 389-393.
17. Uehara, T.; Koike, M.; Nakata, H.; Miyamoto, S.; Motoishi, S.; Hashimoto, K.; Oku, N.; Nakayama, M.; Arano, Y. In vivo recognition of cyclopentadienyltricarbonylrhenium (CpTR) derivatives. Nucl. Med. Biol. 2003, 30, 327-334.
18. Schibli, R.; Schubiger, P. A. Current use and future potential of organometallic radiopharmaceuticals. Eur. J. Nucl. Med. Mol. Imaging 2002, 29, 1529-1542.
19. Mull, E. S.; Sattigeri, V. J.; Rodriguez, A. L.; Katzenellenbogen, J. A. Aryl cyclopentadienyl tricarbonyl rhenium complexes: novel ligands for the estrogen receptor with potential use as estrogen radiopharmaceuticals. Bioorg. Med. Chem. 2002, 10, 1381-1398.
20. Spradau, T. W.; Katzenellenbogen, J. A. Protein and peptide labeling with (cyclopentadienyl)tricarbonyl rhenium and technetium. Bioconjugate Chem. 1998, 9, 765-772.
21. Vogel, M.; Rausch, M.; Rosenberg, H. Derivatives of ferrocene. III. Preparation of acyl- and alkylferrocenes. J. Org. Chem. 1957, 22, 1016-1018.
22. Bhattacharyya, S. Titanium(IV) Chloride-Triethylsilane: An Efficient, Mild System for the Reduction of Acylferrocenes to Alkylferrocenes. J. Org. Chem. 1998, 63, 7101-7102.
23. 99mTc 8-oxooctanoic acid: a novel radiotracer for evaluation of medium chain fatty acid metabolism in the liver. Bioconjugate Chem. 2004, 15, 121-127.
24. Skaddan, M. B.; Wust, F. R.; Jonson, S.; Syhre, R.; Welch, M. J.; Spies, H.; Katzenellenbogen, J. A. Radiochemical synthesis and tissue distribution of Tc-99m-labeled 7alpha-substituted estradiol complexes. Nucl. Med. Biol. 2000, 27, 269-278.
25. Yamamichi, Y.; Kusuoka, H.; Morishita, K.; Shirakami, Y.; Kurami, M.; Okano, K.; Itoh, O.; Nishimura, T. Metabolism of iodine-123-BMIPP in perfused rat hearts. J. Nucl. Med. 1995, 36, 1043-1050.
26. Mori, K.; Hara, Y.; Saito, T.; Masuda, Y.; Nakaya, H. Anticholinergic effects of class III antiarrhythmic drugs in guinea-pig atrial cells: different molecular mechanisms. Circulation 1995, 91, 2834-2843.
27. 123I]IPPA) in the rat heart; identification of new metabolites by high pressure liquid chroma-tography and fast atom bombardment-mass spectrometry. Nucl. Med. Biol. 1993, 20, 747-754.
28. Schmitz, B.; Reske, S. N.; Machulla, H. J.; Egge, H.; Winkler, C. Cardiac metabolism of omega-(p-iodo-phenyl)-pentadecanoic acid: a gas-liquid chromatographic-mass spectrometric analysis. J. Lipid Res. 1984, 25, 1102-1108.
29. Kropp, J.; Ambrose, K. R.; Knapp, F. F., Jr.; Nissen, H. P.; Biersack, H. J. Incorporation of radioiodinated IPPA and BMIPP fatty acid analogues into complex lipids from isolated rat hearts. Int. J. Radiat. Appl. Instrum., Part B 1992, 19, 283-288.
30. 131I]-3(S)-BMIPP show similar metabolism in rat tissues. J. Nucl. Med. 1999, 40, 1918-1927.
31. 186Re chelate-conjugated bisphosphonate for the development of new radiopharmaceuticals for bones. Nucl. Med. Biol. In press.
32. Bonen, A.; Campbell, S. E.; Benton, C. R.; Chabowski, A.; Coort, S. L.; Han, X. X.; Koonen, D. P.; Glatz, J. F.; Luiken, J. J. Regulation of fatty acid transport by fatty acid translocase/CD36. Proc. Nutr. Soc. 2004, 63, 245-249.
33. Brinkmann, J. F.; Abumrad, N. A.; Ibrahimi, A.; van der Vusse, G. J.; Glatz, J. F. New insights into long-chain fatty acid uptake by heart muscle: a crucial role for fatty acid translocase/CD36. Biochem. J. 2002, 367, 561-570.
34. Ehehalt, R.; Fullekrug, J.; Pohl, J.; Ring, A.; Herrmann, T.; Stremmel, W. Translocation of long chain fatty acids across the plasma membrane - lipid rafts and fatty acid transport proteins. Mol. Cell. Biochem. 2006, 284, 135-140.
35. Kung, H. F.; Molnar, M.; Billings, J.; Wicks, R.; Blau, M. Synthesis and Biodistribution of Neutral Lipid-Soluble Tc-99m Complexes that Cross the Blood-Brain Barrier. J. Nucl. Med. 1984, 25, 326-332.
36. 99mTc-PnAO); a potential brain radiopharmaceutical. Eur. J. Nucl. Med. 1984, 9, 511-516.
37. Yokoyama, A.; Yamada, A.; Arano, Y.; Horiuchi, K.; Yamamoto, K.; Torizuka, K. Tc-99m Bifunctional Radiopharmaceutical from a Glucose Derivatives: A Potential Agent for Brain Study. In Technetium in Chemistry and Nuclear Medicine; Deutsch, E., Nicolini, M., Wagner, H., Jr., Eds; Raven Press: New York, 1983; pp 1051-1053.
38. Leveille, J.; Demonceau, G.; Roo, M. D.; Rigo, P.; Taillefer, R.; Morgan, R. A.; Kupranick, D.; Walovitch, R. C. Characterization of Technetium-99m-L,L- ECD for Brain Perfusion Imaging, Part 2: Biodistribution and Brain Imaging in Humans. J. Nucl. Med. 1989, 30, 1902-1910.
39. Neirinckx, R. D.; Canning, L. R.; Piper, I. M.; Nowotink, D. P.; Pickett, R. D.; Holmes, R. A.; Volkert, W. A.; Forster, A. M.; Weisner, P. S.; Marriott, J. A.; Chaplin, S. B. Technetium-99m d.l-HMPAO: A new radiopharmaceutical for SPECT imaging of regional cerebral blood flow. J. Nucl. Med. 1987, 28, 191-202.
40. Machulla, H. J.; Dutschka, K.; Van Beuningen, D.; Chen, T. Development of 15-(p-iodine-123-phenyl)pentadecanoic acid for in vivo diagnosis of the myocardium. J. Radioanal. Chem. 1981, 65, 279-286.
41. Folch, J.; Lees, M.; Sloane, S. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226, 497-509.